http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10351849-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd15fea28fa5c3272dd3e41dcf3b0dd3
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-141
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2016-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57be29f1d1b3af10cbb8f4fb80f98be0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6371e65263c908cfe64d03059f43849b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa81fbfee8f42f3abf3ee48567f2525d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6b96ad93a092dcaaf4c0e84cb0e2794
publicationDate 2019-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-10351849-B2
titleOfInvention Pharmaceutical composition for treating cancer comprising microrna as active ingredient
abstract The present invention relates to a pharmaceutical composition for treatment of cancer, which comprises, as an active ingredient, one or more miRNAs selected from the group consisting of miR-3670, miR-8078, and miR-4477a. The pharmaceutical composition for treatment of cancer according to the present invention exhibits excellent effects of inhibiting cancer cell proliferation and inducing cancer cell apoptosis. Thus, the pharmaceutical composition of the present invention can be effectively used as an anticancer therapeutic agent.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11123361-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022119812-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10987428-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021386860-A1
priorityDate 2015-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014048441-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014100252-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014080894-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2476239-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014078686-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009227533-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012302626-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413479
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1115
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15324
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400163
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107428
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11057
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397853
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400195
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87059198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87057646
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID448537
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393714
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87059199
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11077
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394849
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394850
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413480
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665634
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413481
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413482
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402946

Total number of triples: 68.